Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines about artificial intelligence. Everyone's talking about AI right now. But see, I've been talking about it for years.

I call it my AI Retirement Playbook. I recommend you check it out now.

John Nehra Biography and Net Worth

Director of DaVita

John M. Nehra has been one of our directors since November 2000. From 1989 until his retirement in August 2014, Mr. Nehra was affiliated with New Enterprise Associates (‘‘NEA’’), a venture capital firm, including, from 1993 until his retirement, as general partner of several of its affiliated venture capital limited partnerships. After his retirement in August 2014, Mr. Nehra remained a retired special partner with NEA and continued serving on the board of directors of a number of NEA’s portfolio companies. Mr. Nehra also served as managing general partner of Catalyst Ventures, an affiliate of NEA, from 1989 to 2013.

What is John M. Nehra's net worth?: The estimated net worth of John M. Nehra is at least $2.33 million as of November 1st, 2022. Mr. Nehra owns 15,000 shares of DaVita stock worth more than $2,325,900 as of December 25th. This net worth estimate does not reflect any other investments that Mr. Nehra may own. Learn More about John M. Nehra's net worth.
How do I contact John M. Nehra?: The corporate mailing address for Mr. Nehra and other DaVita executives is 2000 16TH STREET, DENVER CO, 80202. DaVita can also be reached via phone at (720) 631-2100 and via email at [email protected]. Learn More on John M. Nehra's contact information.
Has John M. Nehra been buying or selling shares of DaVita?: John M. Nehra has not been actively trading shares of DaVita during the past quarter. Most recently, on Tuesday, November 1st, John M. Nehra bought 5,000 shares of DaVita stock. The stock was acquired at an average cost of $71.14 per share, with a total value of $355,700.00. Following the completion of the transaction, the director now directly owns 15,000 shares of the company's stock, valued at $1,067,100. Learn More on John M. Nehra's trading history.
Who are DaVita's active insiders?: DaVita's insider roster includes Joel Ackerman (CFO), Pamela Arway (Director), Charles Berg (Director), Barbara Desoer (Director), Paul Diaz (Director), James Hearty (Chief Compliance Officer), John Nehra (Director), Paula Price (Director), Javier Rodriguez (CEO), Michael Staffieri (COO), Kathleen Waters (Insider), and Phyllis Yale (Director). Learn More on DaVita's active insiders.
Are insiders buying or selling shares of DaVita?: In the last year, insiders at the sold shares 11 times. They sold a total of 313,052 shares worth more than $44,636,354.33. The most recent insider tranaction occured on September, 16th when CEO Javier Rodriguez sold 50,000 shares worth more than $8,252,500.00. Insiders at DaVita own 2.0% of the company. Learn More about insider trades at DaVita.
Information on this page was last updated on 9/16/2024.

John M. Nehra Insider Trading History at DaVita

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/1/2022	Buy	5,000	$71.14	$355,700.00	15,000
9/22/2020	Buy	3,000	$84.60	$253,800.00	3,000
3/2/2020	Sell	7,694	$80.74	$621,213.56
2/26/2020	Sell	20,000	$80.93	$1,618,600.00
5/6/2016	Sell	16,314	$75.56	$1,232,685.84	36,665
5/11/2015	Sell	12,278	$81.85	$1,004,954.30
9/16/2014	Sell	20,000	$73.91	$1,478,200.00

John M. Nehra Buying and Selling Activity at DaVita

DaVita Company Overview

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinical research programs; physician services; and comprehensive kidney care services. Further, it engages in the provision of acute inpatient dialysis services and related laboratory services; and transplant software business. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Today's Range

Now: $155.06

$152.23

$155.06

50 Day Range

MA: $156.63

$139.81

$167.98

2 Week Range

Now: $155.06

$103.40

$169.51

Volume

309,941 shs

Average Volume

813,038 shs

Market Capitalization

$12.71 billion

P/E Ratio

16.73

Dividend Yield

N/A

Beta

0.9

Most People Are Dead Wrong.

From Brownstone Research | Ad